University of California San Francisco
Give to UCSFResearchers at UCSF say Google Translate is trustworthy when translating written medical advice, but there are some caveats.
UCSF scientists have used the CRISPR-Cas9 gene-editing system to create the first pluripotent stem cells that are functionally “invisible” to the immune system.
Scientists at UCSF, in collaboration with colleagues at UNC, have developed the world’s largest virtual pharmacology platform and shown it is capable of identifying extremely powerful new drugs.
A new study is using electronic health records to guide management of newborn weight loss.
UCSF scientists have figured out why some lung cancers become drug-resistant after initially responding to targeted therapies.
Video games can offer a safe and easy way for a sedentary population to get started with exercise.
Using a mouse model, researchers showed that a drug that temporarily suppresses a key component of the brain’s immune system can prevent radiation-associated cognitive decline.
A user-friendly website on advance care planning, as well as easy-to-read advance directives, can be highly effective in empowering older adults to plan for their future medical care.
In new studies conducted at UCSF, a novel oxygen-delivery therapeutic restored the function of oxygen-starved heart tissue in an animal model of global hypoxia.
The Chan Zuckerberg Biohub announced awards of $13.7 million over three years for seven teams that include researchers from UC Berkeley, Stanford University and UCSF.
Genetic mutations in a form of non–small cell lung cancer may drive tumor formation by blurring cells’ perception of key growth signals, according to a new laboratory study published Aug. 31, 2018, in Science.
Thanks to a $6.7 million grant, the newly named UCSF-Stanford Pediatric Device Consortium can focus on the development of revolutionary, low-cost gadgets to diagnose and cure pediatric health conditions.
By creating a tailored drug cocktail that matches the mutations of a brain tumor, a new precision medicine approach may move the needle for children with high-grade gliomas.
Researchers have identified a new strategy for potentially treating a subset of intractable cancers by decoupling the entire RAS / MAP Kinase signaling pathway from external growth signals.